Dephosphorization of Manganese Ore Raw Materials

The dephosphorization of manganese ores and concentrates in a reducing atmosphere is thermodynamically analyzed. It is shown that phosphorus can completely pass to a gas phase in a closed reaction system in a wide temperature range (1273–2073 K) at the amounts of a reducing gas (CO) that exceed the stoichiometric minimum required for reduction reactions. The gaseous products of reduction is found to contain phosphorus in the form of mainly polyatomic “heavy” molecular oxides, which can decrease the real effect of dephosphorization as compared to that obtained by equilibrium calculations because of kinetic factors. A thermodynamic simulation of a flow reaction system shows that almost complete transition of phosphorus to light gaseous substances (PO, P2) is thermodynamically possible at the temperatures that are close to the technological operation temperatures. This transition is provided by the ratio of the rate of formation of volatile phosphorus-containing substances to the rate of their removal from reaction regions. Keywords: manganese ores, manganese concentrates, phosphorus, carbon monoxide, reductio

Impact of potential inappropriate NSAIDs use in chronic pain

Abstract: Pain remains one of the main reasons for medical consultation worldwide: moderate- to severe-intensity pain occurs in 19% of adult Europeans, seriously affecting the quality of their social and working lives. Nonsteroidal anti-inflammatory drugs (NSAIDs) are not recommended for long-term use and a careful surveillance to monitor for toxicity and efficacy is critical. This study aims to assess: 1) the pattern of use of NSAIDs and opioids in a population covered by a cloud-based pharmacovigilance surveillance system; and 2) potential inappropriate use. A retrospective 18-months systematic analysis on patients\u2019 pain treatment was performed. The primary endpoint was evaluating the prevalence of NSAIDs and opioids use and the duration of therapy regimen. The secondary endpoint was to investigate the prevalence of NSAIDs taken for \ue02e21 consecutive days concomitant with drugs for peptic ulcer and gastroesophageal reflux disease (GORD) or antiplatelet drugs. The yearly cost for individual users of concomitant NSAIDs for more than 21 consecutive days and of GORD medications has been estimated. A total of 3,050 subjects with chronic pain were enrolled; 97% of them took NSAIDs for \ue02e21 consecutive days; about one-fourth of these users also received drugs for peptic ulcer and GORD (Anatomical Therapeutic Chemical code A02B). The yearly cost foran individual who uses NSAIDs for \ue02e21 consecutive days as well as concomitant GORD medications is 61.23 euros. In total, 238 subjects (8%) using NSAIDs for \ue02e21 days also received one antiplatelet agent. About 11% of subjects received opioids at least once and only 2% of them carried on the therapy for more than 90 consecutive days. In evaluating the escalation in dosage as a proxy of dependence risk, this study shows no dosage escalation in our cohort of chronic pain population - that is to say we show no risk of dependence. Keywords: pain therapy, economic impact, dependenc